KYLIE KATTELUS: Open Payments
NPI 1467044941 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,904 in 120 payments from 16 companies in 2025. Trend: 2023 $2,237 · 2024 $5,004 · 2025 $6,904
Speaker / faculty: $4,104Food & beverage: $2,006Consulting: $795
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $4,612 |
| Lundbeck LLC | 18 | $1,051 |
| PFIZER INC. | 21 | $279 |
| Axsome Therapeutics, Inc. | 9 | $244 |
| UCB, Inc. | 5 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $116 |
| Eisai Inc. | 6 | $104 |
| Lilly USA, LLC | 4 | $76 |
| Neurelis, Inc. | 3 | $60 |
| JAZZ PHARMACEUTICALS INC. | 2 | $52 |
Products named: QULIPTA, VYEPTI, NURTEC ODT, Symbravo, HYQVIA, Fintepla, Leqembi, VALTOCO.
Industry payments across MI — which companies pay providers there.
